IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—24 December 2013

2:20 AM MST | December 24, 2013 | Deepti Ramesh

Perrigo completes acquisition of Elan for $8.6 billion Health-care products firm Perrigo (Allegan, MI) says that it has completed the previously announced acquisition of biotechnology company Elan (Dublin), for about $8.6 billion. Perrigo and Elan have been combined under a new company incorporated in Ireland and have adopted the global name Perrigo Co. plc. Shares of Perrigo will trade on the New York Stock Exchange and the Tel Aviv Stock Exchange. Perrigo develops, manufactures, and distributes OTC and generic prescription pharmaceuticals, nutritional products...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa